MERS-CoV: Illinois Man Shows Evidence of Past Infection – US Investigation Update

An Illinois resident who had close contact with the first confirmed U.S. Case of Middle East Respiratory Syndrome (MERS) has tested positive for the virus, health officials announced Wednesday. The confirmation, stemming from ongoing investigations into the Indiana case, represents a potential, though limited, expansion of the outbreak within the United States. While this development warrants careful monitoring, public health authorities emphasize that the risk to the general public remains low.

Understanding MERS-CoV

MERS-CoV, or Middle East Respiratory Syndrome-related Coronavirus, is a virus belonging to the Betacoronavirus genus. It was first identified in Saudi Arabia in 2012 and causes the disease Middle East Respiratory Syndrome (MERS). The virus is zoonotic, meaning it originates in animals – specifically, bats – and can transmit to humans. Camels are considered a major reservoir for MERS-CoV, and human-to-human transmission, while not as efficient as with viruses like influenza or SARS-CoV-2, can occur, particularly in healthcare settings. The World Health Organization (WHO) lists MERS-CoV as one of several viruses with pandemic potential, prompting ongoing research and surveillance efforts.

The virus enters host cells by binding to the DPP4 receptor, a protein found on the surface of cells in the lungs, kidneys, and intestines. Symptoms of MERS typically include fever, cough, shortness of breath, and potentially more severe complications like pneumonia, kidney failure, and even death. There is currently no specific vaccine or antiviral treatment for MERS, and care focuses on supportive measures.

The U.S. Cases: Indiana and Illinois

The initial U.S. Case, reported in April 2014, involved a healthcare worker in Indiana who had recently traveled to the Middle East. The Illinois resident had a business meeting with this individual prior to the Indiana patient’s hospitalization. Initial testing raised concerns, but subsequent, more definitive laboratory tests confirmed the Illinois resident had been infected with MERS-CoV. The Centers for Disease Control and Prevention (CDC) conducted the follow-up testing and announced the confirmation on May 28, 2014.

Crucially, health officials determined that the Illinois resident’s infection represented a past exposure to the virus. In other words the individual was infected during the business meeting but did not subsequently spread the virus to others. This conclusion was reached after extensive contact tracing and testing of individuals who had been in contact with the Illinois resident.

What the Evidence Shows – and Doesn’t

The confirmation of the Illinois case highlights the potential for limited transmission of MERS-CoV outside of the Middle East, even with relatively brief contact. However, it as well underscores the fact that the virus is not easily spread. The CDC’s investigation involved a thorough review of the contact history of both patients, as well as laboratory testing to confirm the presence of the virus and to differentiate between active infection and past exposure.

It’s important to note that the CDC’s conclusions are based on the available evidence at the time of the investigation. As detailed in a report published in the Morbidity and Mortality Weekly Report (MMWR), the investigation involved collaboration between the CDC, the Indiana State Department of Health, and local health departments. The report also outlines the public health measures taken to contain the potential spread of the virus, including contact tracing, quarantine, and monitoring of individuals who had been exposed.

The investigation did not establish the precise mechanism of transmission between the two individuals. It’s possible that transmission occurred through respiratory droplets produced during coughing or sneezing, or through direct contact with contaminated surfaces. However, the limited extent of transmission suggests that the virus may not have been shed in high quantities, or that the contact was not prolonged enough to facilitate infection.

Implications for Public Health

The 2014 cases prompted a review of U.S. Preparedness for MERS-CoV. The CDC issued guidance to healthcare providers on how to recognize and report suspected cases of MERS, as well as recommendations for infection control practices to prevent the spread of the virus in healthcare settings. These recommendations included the use of personal protective equipment (PPE), such as masks, gowns, and gloves, and the implementation of strict hand hygiene protocols.

The incident also reinforced the importance of travel awareness. Individuals traveling to the Middle East were advised to avoid close contact with camels and to practice good hygiene, such as frequent handwashing. Travelers returning from the Middle East who developed respiratory symptoms were urged to seek medical attention and to inform their healthcare provider of their travel history.

Ongoing Surveillance and Future Considerations

The CDC continues to monitor for MERS-CoV cases in the United States and around the world. Surveillance efforts include tracking reported cases, analyzing viral sequences to identify emerging strains, and conducting research to better understand the virus and its transmission dynamics.

In 2022, the identification of NeoCoV, another MERS-related coronavirus in bats, raised concerns about the potential for future outbreaks. While NeoCoV has not yet been shown to infect humans, it shares similarities with MERS-CoV and has the potential to cause severe disease. Ongoing research is focused on characterizing NeoCoV and assessing its risk to human health.

What comes next involves continued vigilance. Public health agencies will maintain surveillance systems, refine diagnostic capabilities, and update guidance as new information becomes available. Individuals should stay informed about MERS-CoV and other emerging infectious diseases by consulting official public health resources, such as the CDC and WHO websites. If you develop respiratory symptoms and have a history of travel to the Middle East or contact with individuals who have traveled to the region, consult a qualified healthcare professional.